HWMA
PCRX icon

Heritage Wealth Management (Arizona)’s Pacira BioSciences PCRX Stock Holding History

Heritage Wealth Management (Arizona)’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$233K Buy
6,024
+3,314
+122% +$161K 0.03% 316
2022
Q3 		$144K Buy
2,710
+97
+4% +$5.39K 0.05% 288
2022
Q2 		$152K Buy
2,613
+280
+12% +$18.3K 0.05% 283
2022
Q1 		$178K Buy
+2,333
New +$156K 0.05% 288
2021
Q3 		$72K Buy
1,291
+638
+98% +$36.8K 0.03% 401
2021
Q2 		$40K Buy
+653
New +$41.3K 0.02% 489

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Heritage Wealth Management (Arizona)'s PCRX Position: Q4 2022 in Review

Heritage Wealth Management (Arizona) increased its Pacira BioSciences (PCRX) stake by 122% in Q4 2022, buying an estimated $161K and bringing the position to 6,024 shares worth $233K. The position accounts for 0.03% of the portfolio, ranked #316.

Heritage Wealth Management (Arizona) first reported a position in PCRX in Q2 2021 and has held it in 6 quarters since. 273 funds tracked by Wall St. Rank hold PCRX as of Q4 2022.

  • Heritage Wealth Management (Arizona) held 6,024 shares of Pacira BioSciences worth $233K as of Q4 2022.
  • Heritage Wealth Management (Arizona) bought 3,314 Pacira BioSciences shares in Q4 2022, an estimated $161K.
  • Pacira BioSciences made up 0.03% of Heritage Wealth Management (Arizona)'s portfolio in Q4 2022, its #316 holding.
  • Heritage Wealth Management (Arizona) first reported a position in Pacira BioSciences in Q2 2021 and has held it in 6 quarters since.
  • 273 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2022.

Based on Heritage Wealth Management (Arizona)'s 13F filing for Q4 2022, filed 13 Feb 2023.